Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
19 hedge funds and large institutions have $2.16M invested in Nemaura Medical, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 0 closing their positions.
12% more funds holding
Funds holding: 17 → 19 (+2)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
42% less capital invested
Capital invested by funds: $3.7M → $2.16M (-$1.54M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIP
ARS Investment Partners
New York
|
+$31.5K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.68K |
| 3 |
IAMOG
Investors Asset Management of Georgia
Atlanta,
Georgia
|
+$1.6K |
| 4 |
GIA
GHP Investment Advisors
Denver,
Colorado
|
+$1.28K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$22 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$60.3K |
| 2 |
BlackRock
New York
|
-$1.44K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$567 |
| 4 |
Morgan Stanley
New York
|
-$442 |
NMRD Hedge Fund Activity: Q2 2022 in Review
19 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q2 2022, worth a combined $2.16M — down 42% from $3.7M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new NMRD positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was ARS Investment Partners, adding an estimated $31.5K. The largest seller was Susquehanna International Group, cutting an estimated $60.3K.
- 19 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q2 2022, up from 17 in Q1 2022.
- Funds reported $2.16M of Nemaura Medical, Inc. Common Stock stock for Q2 2022, down 42% quarter-over-quarter.
- 2 funds opened new Nemaura Medical, Inc. Common Stock positions in Q2 2022 and 0 closed out, a net change of +2 holders.
- The largest Nemaura Medical, Inc. Common Stock buyer in Q2 2022 was ARS Investment Partners, an estimated $31.5K added.
- The largest Nemaura Medical, Inc. Common Stock seller in Q2 2022 was Susquehanna International Group, an estimated $60.3K sold.
Based on aggregated 13F filings for Q2 2022.